Blood volume monitoring-guided hemodialysis was found to decrease hospital stay by 2 days and lead to significantly fewer readmissions for patients with end-stage kidney disease and heart failure. A multicenter cohort study conducted from 2017 to 2020 with 278 hospitalized patients showed that those who received dialysis with blood volume monitoring had a shorter hospital length of stay and fewer readmissions compared to those without this monitoring. The study emphasized the importance of using technologies like the Crit-Line IV Monitor for patients with heart failure to improve outcomes. These findings were presented at ASN Kidney Week in San Diego.
Source link
Blood volume monitoring tied to shorter hospital stays, fewer readmissions for some adults
